Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Ozarelix, in Patients With Lower Urinary Tract Symptoms(LUTS)Due to Benign Prostatic Hypertrophy (BPH)
Brief Summary: This study will compare the efficacy and safety of ozarelix 15 mg. given IM 2 weeks apart on the improvement of symptoms and the duration of improvement for up to 6 months in men with BPH who are over 50 years of age.